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Background: Abnormal uterine bleeding (AUB) is one of the most common debilitating menstrual problems and
has remained one of the most frequent indications for hysterectomy in developing countries. Approximately in 40%
of hysterectomy specimens, no definite organic pathology could be established. The problem is common worldwide
but causes may vary from one region to another. This study may help gynecologists in our population to improve their
therapeutic strategies by promoting minimally invasive uterus sparing modalities such as endometrial ablation and
hysteroscopic resection of early proliferative lesions.
Methods: It was a prospective, cross-sectional study conducted at Liaquat National Hospital from 15th January 2010 till
14th July 2011 over a period of 18 months. Women who underwent dilatation and curettage for endometrial sampling
with complaints of AUB were included in the study and histopathologic spectrum was determined.
Results: Polymenorrhea was the most common presenting pattern (30%, 72/241) with reproductive age women being
the most susceptible (49.3%,119/241). The commonest histopathological spectrum was normal menstrual pattern (34%,
82/241) and the commonest pathology was hormonal imbalance (27%, 65/241), followed by endometrial polyp (14%,
34/241), chronic endometritis (12%, 28/241), atrophic endometrium (6%, 15/241), endometrial hyperplasia (5%, 12/241),
and endometrial carcinoma (2%, 5/241). Chronic endometritis was commonly seen in reproductive age (18%, 21/119);
hormonal imbalance (45%, 35/77) and endometrial hyperplasia (6.5%, 5/77) in perimenopausal age; endometrial polyp
(35.5%, 16/45) and endometrial carcinoma (9%, 4/45) in postmenopausal age.
Conclusion: Frequency of benign endometrial pathology is quite high in AUB, 236 participants (98%, 236/241).
Histopathological spectrum in patients with AUB is quite variable with respect to age. The most common pattern
of AUB was polymenorrhea. The most common pathology was hormonal imbalance. It is suggested that age was
associated with more progressive lesions found in peri and postmenopausal age group such as endometrial
hyperplasia and endometrial carcinoma. Yet endometrial polyp was the most common pathology found in
postmenopausal women. Therefore, the management strategy should be individualized, as in most cases a
restrictive approach is appropriate in order to avoid unnecessary hysterectomies.
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Menstrual problems account for much of the morbidity,
affecting one in every five women during their life span.
Specifically, abnormal uterine bleeding (AUB) is one
of the most common debilitating menstrual problems.
A study based on epidemiology of menstrual disorders
in developing countries revealed that the prevalence of
AUB in developing countries including Pakistan was about
5-15% [1]. Within the study period there were 400 AUB
cases out of 1600 gynaecological cases which gave an AUB
prevalence of 25% per 100 gynaecological cases. Out of
400 AUB cases, 241 (60%) participants were recruited into
the study. Risk factors of AUB include female genital tract
pathologies, pregnancy related disorders, and systemic
illnesses [2].
Spectrum of common pathologies that can be detected
histologically in AUB include hormonal imbalance pattern
(disorderly proliferative endometrium, non secretory endo-
metrium with stromal and glandular breakdown, luteal
phase defect and pill effect) atrophic endometrium, endo-
metritis, endometrial polyp, endometrial hyperplasia and
endometrial carcinoma. However endometrial pathologies
were noted in only about half of the cases of AUB and
hormonal imbalance pattern dominated the clinical pic-
ture [3,4].
AUB has remained one of the most frequent indications
for hysterectomy in developing countries but 40% of cases
were not associated with any definitive organic pathology
[5]. Hysterectomy is often correlated with complications
such as bleeding, bladder or bowel damage, infection,
thrombosis, ovary failure and early onset of menopause
[6]. Prevalence of abnormal uterine bleeding in devel-
oping countries including Pakistan is about 5-15% [1].
One half of women by age 45.5 years, three quarter by
age 47.8 years & 95% by age 50.8 years experience men-
strual disturbance [1]. It has been estimated that around
6% of women aged 25–44 years consult their general phys-
ician about excessive menstrual loss every year, around
35% of these referred to hospital and 60% of them under-
went hysterectomy in the next 5 years. Over 75000 hyster-
ectomies are now carried out every year & 25-30% of them
are for menstrual disturbance [7].
Hysterectomy is associated with high rate of morbidity
(Ureteral injuries are common, owing to the size and loca-
tion of the ureter, Bladder injuries occur in up to 2% of
cases, hemorrhage occurs in 1% to 3% of patients, atel-
ectasis, fallopian tube prolapse, thromboembolic disease,
myocardial infarction, stroke, and renal failure) [3] and is
employed as last prerogative in management of AUB in de-
veloped countries due to availability of minimally invasive
surgical (MIS) modalities such as endometrial ablation and
thermal balloon therapy [6,8,9]. MIS is equated with faster
recovery, less pain, smaller incisions and shorter hos-
pital stays. Hysteroscopic resection has proved invaluablein treating atypical proliferative lesions of endometrium as
an alternative to hysterectomy [10].
Since endometrium is the best accessible tissue for histo-
pathological evaluation of uterine bleeding, several methods
are used for endometrial sampling among which Dilatation
and Curettage is considered to be a method of choice [11]
therefore used as standard practice in our set up. The aim
of the present study was to determine the clinical spectrum
and frequency of pathologies in endometrial biopsy of pa-
tients with AUB in our population.
Methods
It was a prospective cross-sectional study conducted at
Liaquat National Hospital (LNH) from 15th January 2010
till 14th July 2011. Ethics committee of Liaquat National
hospital approved the study. LNH is a private sector ter-
tiary care hospital serving the society for the last 56 years
having approximately 700 beds with 30 medical and sur-
gical specialties providing both inpatient and outpatient
services. The sampling technique was consecutive non-
probability purposive. Women who underwent dilatation
and curettage (D & C) for endometrial sampling with com-
plaints of AUB were included in the study and standard
operating procedures were followed for obtaining histo-
pathological sample [12]. All procedures were carried out
by 3 different gynaecologists with more than 3 year post
fellowship experience. The gynaecologists were blinded to
the study objective. 241 endometrial biopsies fulfilling the
inclusion criteria were included. Age, duration of abnormal
uterine bleeding and observed histopathological spectrums
were recorded on proforma and standard operating pro-
cedure were followed in specimen handling. Patients with
systemic illness/cause of bleeding like low platelet count
or miscarriage were excluded from the study. Informed
consent was taken prior to procedure and an approval
from institutional ethical review committee was taken
antecedent to conducting the study. Cases were stratified
into reproductive, peri-menopausal and post-menopausal
age groups. Reproductive age was considered from puberty
to perimenopausal age (approx. 12 to 39 years). Peri-
menopausal age was around menopause, and was different
for every woman (approx. 40–50 years). Postmenopausal
age group was defined as permanent cessation of menstru-
ation, confirmed after 12 consecutive months of amenor-
rhea (average age 50 years onwards).
Specimens were immediately put in 10% formalin, ap-
propriately labeled for patients name, gender, age and type
of procedure/specimen and transferred to histopathology
laboratory where a specific ID number was given to each
specimen. Grossing of specimens was done using stand-
ard protocols and measurements were recorded. Tissue
processing was performed and slides were stained with
hematoxylin and eosin stains under strict quality assur-
ance. Microscopic evaluation was done by two consultant
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than 5 years, blinded to the objectives of the study. Each
sample was evaluated independently by the two consultant
histopathologists when required. Data was entered into SPSS
version 10. Results were presented as mean ± SD for age,
frequencies and percentages was computed for descriptive
variables i.e. normal menstrual pattern, hormonal imbalance
pattern, endometrial polyp, chronic endometritis, atrophic
endometrium, endometrial hyperplasia and endometrial car-
cinoma. Stratification of age and duration of abnormal
uterine bleeding was done to control the confounding fac-
tor. Sample size was 241, calculated by taking endometrial
carcinoma as the least prevalent pathology (p= 6%, d= 5%,
confidence level as 95%).
Definitions [11]
Menorrhagia
Prolonged (>7 days) or excessive (>80 mL daily) uterine
bleeding occurring at regular intervals.
Metrorrhagia
Uterine bleeding occurring at irregular and more frequent
than normal intervals.
Menometrorrhagia
Prolonged or excessive uterine bleeding occurring at irregu-
lar and more frequent than normal intervals.
Intermenstrual\irregular bleeding
Uterine bleeding of variable amounts occurring between
regular menstrual periods.
Polymenorrhea
Uterine bleeding occurring at regular intervals of less
than 21 days.
Oligomenorrhea
Uterine bleeding occurring at intervals of 35 days to
6 months.
Post menopausal bleeding
Bleeding after physiologic cessation (12 months or more)
of menstruation.
Results
Within the study period there were 400 AUB cases out
of 1600 gynaecological cases which gave an AUB preva-
lence of 25% per 100 gynaecological cases. Out of 400 AUB
cases, 241 (60%) participants were recruited into the study.
Patients’ mean age was 40.3 years ±11.06 (18 – 75 years).
Reproductive age group was the most common age group,
119 participants (49.3%, 119/241) presented with AUB,
followed by peri-menopausal, 77 participants (32%, 77/241)and post menopausal age group, 45 participants (18.7%,
45/241).
175 participants were married (72.6%, 175/241) and 66
were unmarried (27.3%, 66/241).
72 participants (30%, 72/241) presented with polyme-
norrhea which was the most common pattern followed
by irregular bleeding (26%, 64/241) (Figure 1). Major histo-
logical patterns observed were as follows, normal menstrual
pattern in 82 participants (34%, 82/241), hormonal imbal-
ance pattern in 65 (27%, 65/241), endometrial polyp in 34
(14%, 34/241), chronic endometritis in 28 (12%, 28/241),
atrophic endometrium 15 (6%, 15/241), endometrial hyper-
plasia in 12 (5%, 12/241) and endometrial carcinoma was
noted in 5 (2%, 5/241) participants (Table 1). Therefore
endometrial pathologies were observed in 159 (66%, 159/
241) participants (Figure 2), whereas normal menstrual
pattern was seen in 82 (34%, 82/241) participants, of AUB.
Among 82 normal menstrual pattern, secretory endo-
metrium was the most common pattern i.e. 49 (60%, 49/
82) participants, followed by proliferative pattern endomet-
rium 33 (40%, 33/82) participants. Hormonal imbalance
pattern, chronic endometritis, endometrial hyperplasia
and endometrial carcinoma was further stratified for de-
tailed analysis. Among 64 cases of hormonal imbalance pat-
tern, 52 participants, (81%, 52/64) were estrogen related
and 12 participants (19%, 12/52) were progesterone associ-
ated. Among 28 cases of chronic endometritis, non-specific
endometritis was observed in 27 cases (96.4%, 27/28),
whereas only 1 (3.6%, 1/28) participants showed chronic
granulomatous inflammation. Among 12 participants of
endometrial hyperplasia, 7 participants (58%, 7/12) showed
atypia whereas 5 participants (42%, 5/12) were without
atypia. Among 5 participants of endometrial carcinoma,
type I endometrial carcinoma was noted in 4 participants
(80%, 4/5) while type 2 endometrial carcinoma was noted
in 1 participants.
Stratification of age was done and frequency of endo-
metrial pathologies was observed in different age groups
(Table 2). In reproductive and peri-menopausal age groups
hormonal imbalance pattern followed by endometrial polyp
dominated the pathologic picture while in postmenopausal
age group, endometrial polyp was the most frequent path-
ology (35.5%, 16/45) followed by atrophic endometrium
(33.3%, 15/45). On the other hand the frequency of endo-
metrial hyperplasia and carcinoma was quite low, 13.2%
(6/45) and 9% (4/45) respectively (Table 2).
Thus in all 241 participants 236 (98%, 236/241) had
benign histopathological spectrum; whereas malignancy
was observed in only 5 participants (2%, 5/241).
Discussion
Uterine bleeding presents as the most common symptom
that confronts gynecologists, and poses a considerable
health risk. AUB is excessive, erratic, or irregular bleeding
Figure 1 Clinical pattern of abnormal uterine bleeding n= 241.
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intrauterine pathology. It has been estimated that around
6% of women aged 25–44 years consult their general phys-
ician due to excessive menstrual loss every year. One of
the major causes of excessive or erratic menstruation
is inadvertent use of contraceptive modalities. In the
past, repeated childbirth and lactation caused prolonged
amenorrhea, thus alleviating proliferative activity of endo-
metrium. AUB is of concern because it may have serious
medical and social consequences, as bleeding may cause
anemia, undue disruption of women’s daily activities and
sexual life.
Endometrial assessment is performed to diagnose ma-
lignancy or pre-malignant conditions and to evaluate the
hormonal influences of the endometrium. It is important
to evaluate the endometrial histopathology in a woman
who has no improvement in her bleeding pattern following
a course of medical therapy of three months [12]. It is wellTable 1 Histopathological spectrum in patients with
abnormal uterine bleeding
Histopathological spectrum n (%)
Normal menstrual pattern 82 (34%)
Hormonal imbalance 65 (27%)
Endometrial polyp 34 (14%)
Chronic endometritis 28 (12%)
Atrophic endometrium 15 (6%)
Endometrial hyperplasia 12 (5%)
Endometrial carcinoma 05 (2%)
Total 241 (100%)established that AUB is significant cause of morbidity, but
the underlying causes of AUB may vary from one region to
another.
A total of 241 endometrial samples of patients with
abnormal uterine bleeding were assessed. Maximum fre-
quency of AUB was observed in reproductive (18-39 years)
age group (49.3%, 119/241) followed by perimeopausal
(40-50 years) (32%, 77/241) and postmenopausal (51
above) age groups (18.7%, 45/241). We observed that age
was as an important factor governing the histological pro-
gression. Age was directly associated with increasing ag-
gressiveness of lesions since more progressive lesions were
found in peri and postmenopausal age group as compared
to reproductive age group.
Abnormal uterine bleeding may present with variable
patterns. Our study showed 30% (72/241) participants pre-
sented with polymenorrhea, 22% (53/241) with menorrha-
gia, 26% (64/241) with irregular bleeding, 3% (7/241) with
menometrorrhagea and 19% (45/241) with post-menopausal
bleeding.
We observed 34% (82/241) participants with normal
menstrual pattern of endometrium while endometrial path-
ologies were noted in 66% (159/241). Among 82 cases of
normal pattern endometrium, secretory pattern was seen in
60% (49/82) participants and proliferative pattern in 40%
(33/82).
Among 159 cases of endometrial pathologies, hormonal
imbalance pattern was the most frequent pathology (41%,
65/159). The histological spectrum observed in hormonal
imbalance pattern among 65 cases was estrogen related
pattern in 80% (52/65) and progesterone related pattern in
20% (13/65). Hormonal imbalance pattern was seen most
Figure 2 Frequency of endometrial pathologies n= 159.
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This correlates with the fact that perimenopausal age is a
transition from normal ovulation to anovulation.
Endometrial polyp was observed in 14% cases (34/241),
whereas among endometrial pathologies its frequency was
found to be 21%, 34/159. We observed an increase in fre-
quency of polyp with increasing age i.e. 8.4% in reproduct-
ive age group, 10.4% in perimenopausal age group and
35.5% in postmenopausal age group. Although polyp was
the second most common pathology after hormonal im-
balance pattern, nonetheless it is not regarded as a major
risk factor for the development of carcinoma. Further-
more, endometrial polyp was the most common pathology
in postmenopausal women in our study. None of the
polyps showed atypical changes suggestive of development
of carcinoma. Similar trends were observed in national
studies [12,13]. Azim et al. demonstrated an increased
frequency of polyp with advancing age 5%, 8% and 11% in
reproductive, perimenopausal and postmenopausal ageTable 2 Histopathological spectrum in reproductive, peri and
Endometrial pathologies Reproductive age group
Hormonal imbalance 26 (22%)
Endometrial polyp 10 (8.4%)
Chronic endometritis 21 (18%)
Atrophic endometrium 0 (0%)
Endometrial hyperplasia 1 (1%)
Endometrial carcinoma 0 (0%)
Normal menstrual pattern 61 (51%)
Total (241) 119groups respectively [14]. Dresiler et al. also observed the
same findings in Danish population [15].
Among 28 cases of chronic endometritis 97% (27/28)
showed nonspecific endometritis and only 3% (1/28) showed
chronic granulomatous inflammation. This entity was
most commonly seen in reproductive and perimeno-
pausal age group, since these age groups have a greater
chance of exposure to caesarian sections, spontaneous and
therapeutic abortion and intrauterine contraceptive de-
vices etc. hence, prone to develop chronic endometritis.
Some variation has been observed among national studies,
Muzaffar et al. at Rawalpindi observed chronic endometri-
tis in 13% [16], whereas Perveen et al. at Karachi in 37%
participants [17]. The variation may be due to socioeco-
nomic status, hygienic conditions or exposure to surgical
intervention. On the other hand, since chronic endometri-
tis may be due to some underlying pathology such as
retained products of conception etc. a higher frequency
of non-specific chronic endometritis in these studies maypostmenopausal age groups
Perimenopausal age group Postmenopausal age group
35 (45.5%) 4 (9%)
8 (10.4%) 16 (35.5%)
7 (9.1%) 0 (0%)
0 (0%) 15 (33.3%)
5 (6.5%) 6 (13.2%)
1 (1.2%) 4 (9%)
21 (27.3%) 0 (0%)
77 45
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Meticulous attention to the endometrial sampling tech-
nique is needed in such circumstances.
We observed atrophic endometrium in 6% (15/241) and
all patients were in the post menopausal age group, whereas
reproductive and perimenopausal age group showed no
such pattern. Anovulation seen in perimenopausal age
group eventually leads to permanent loss of ovarian func-
tion manifested as atrophic or inactive endometrium.
Among postmenopausal age group atrophic endomet-
rium was found to be the second most common path-
ology (33%, 15/45).
Endometrial hyperplasia is the precursor of carcinoma
and usually presents with abnormal uterine bleeding. We
observed endometrial hyperplasia in 5% (12/241) partici-
pants, out of those 54% (7/12) showed hyperplasia with
atypia and 46% (5/12) without atypia. It was seen most
frequently in postmenopausal age group (46%) followed
by perimenopausal (38.5%) and reproductive age group
(15.5%) respectively. Perveen et al., Muzzafer et al. and
Luqman et al. reported (96, 12%), (101, 24.7%) and (103,
14%) respectively [16-18]. Variation in population charac-
teristics and use of hormonal therapy may also be the con-
tributory factors to these differences, as use of estrogen
therapy declined after its role in the development of endo-
metrial carcinoma was uncovered. Varying incidence of
endometrial hyperplasia was also evident in international
literature. Behnamfar et al. evaluated cystic and adenoma-
tous hyperplasia in addition to other patterns and reported
an incidence of 9% and 10.9% respectively [15]. On the
other hand, Dexus and Jyotsana reported higher frequency
of endometrial hyperplasia, 21% and 22.6% respectively
[13,19].
The frequency of endometrial carcinoma was low in our
study (2%, 5/241). Type 1 endometrial carcinoma was seen
in majority (80%, 4/5) while Type 2 in only 1 participant
which is considered to be more aggressive (20%, 1/5). It
was seen most commonly in post menopausal age group
(4, 80%) followed by perimenopausal (1, 20%). These find-
ing are similar to various national studies, where most of
the investigators found a frequency of endometrial
carcinoma in less than 1% cases [11,17]. We observed
endometrial carcinoma was most commonly seen in post-
menopausal age group yet its frequency was only 9%
among other pathologies in this particular age group
which is slightly lower than the Nepalese regional study
who observed endometrial carcinoma in 17.6% [20] and
Chinese Feng Y observed even higher incidence of endo-
metrial carcinoma of 50% in PMB cases respectively [21].
The lower incidence of endometrial carcinoma in our
population can be associated with early childbearing and
multiparity. Proliferative activity markedly declines during
pregnancy explaining the lower incidence of hyperplastic
and neoplastic lesions in our population.Due to its descriptive nature, our study may not be
complete in all aspects. However, this study would pro-
vide a data base with regard to the histopathological spec-
trums in abnormal uterine bleeding in our population. This
data base may help gynaecologist to modify their treatment
strategies. Furthermore, based on common endometrial
pathologies in our population, health literacy, screening
programme etc., can be constructed effectively.
Conclusion
Abnormal uterine bleeding was common at Liaquat Na-
tional Hospital, Karachi, Pakistan and the commonest pres-
entation was polymenorrhea. Histopahologically, most
of the cases were benign-hormonal imbalance and the
endometrial polyps were the commonest pathology in the
reproductive age women and the post-menopausal women
respectively. Therefore, management of AUB in our envir-
onment should be individualized and more restrictive with
a view to conserve the uterus. Although a thorough endo-
metrial sampling is recommended in post-menopausal
women due to focal nature of endometrial polyps.
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